Kestra Medical Technologies (KMTS) Reiterated at Buy by Stifel as Sales Guidance Raised

September 15, 2026 6:59 AM

Stifel analyst Rick Wise reiterated a Buy rating and $30.00 price target on Kestra Medical Technologies (NASDAQ: KMTS).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found